Literature DB >> 6148129

Morphologic and neurochemical studies of embryonic brain development in murine trisomy 16.

H S Singer, M Tiemeyer, J C Hedreen, J Gearhart, J T Coyle.   

Abstract

Telencephalic and diencephalic/brainstem regions from embryonic trisomy-16 mice (Ts16) between gestational days 15-18 were analyzed for alterations of morphologic and neurochemical parameters and compared to phenotypically normal littermates. Mean trisomic wet weights from both regions were significantly diminished (greater than 20%) and total protein content was reduced. Ratios of the thickness of the ventricular (germinal) zone to the thickness of the whole cortex were increased, suggesting a delay in neuronal differentiation. Pre- and postsynaptic markers for GABAergic, cholinergic, catecholaminergic and serotonergic transmitter systems were compared. A significant impairment of the trisomic brain catecholaminergic and serotonergic system development was observed, based upon regional reductions in norepinephrine, dopamine and serotonin content. Choline acetyltransferase activity in the diencephalon/brainstem was reduced by 21-26% in contrast to normal levels within the cerebral hemispheres. Presynaptic GABAergic markers were not affected in the Ts16 embryos. It is concluded that although a genetic imbalance involving chromosome 16 in the mouse embryo produces a delay in neurogenesis, it has a more selective effect on the catecholaminergic, serotonergic and cholinergic systems than on GABAergic neurons.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6148129     DOI: 10.1016/0165-3806(84)90093-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Nerve growth factor corrects developmental impairments of basal forebrain cholinergic neurons in the trisomy 16 mouse.

Authors:  P Corsi; J T Coyle
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

2.  Blastomere karyotyping and transfer of chromosomally selected embryos. Implications for the production of specific animal models and human prenatal diagnosis.

Authors:  C Bacchus; W Buselmaier
Journal:  Hum Genet       Date:  1988-12       Impact factor: 4.132

3.  Somatostatin expression in TS16 mouse brain cultures.

Authors:  P Corsi; G Forloni; M Troia; T Lettini; J T Coyle
Journal:  J Mol Neurosci       Date:  1998-04       Impact factor: 3.444

4.  Glutamate as a hippocampal neuron survival factor: an inherited defect in the trisomy 16 mouse.

Authors:  L L Bambrick; P J Yarowsky; B K Krueger
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

5.  Dysregulation of gene expression in mouse trisomy 16, an animal model of Down syndrome.

Authors:  D M Holtzman; R M Bayney; Y W Li; H Khosrovi; C N Berger; C J Epstein; W C Mobley
Journal:  EMBO J       Date:  1992-02       Impact factor: 11.598

6.  Altered development of dopaminergic neurons differentiated from stem cells from human exfoliated deciduous teeth of a patient with Down syndrome.

Authors:  Thanh Thi Mai Pham; Hiroki Kato; Haruyoshi Yamaza; Keiji Masuda; Yuta Hirofuji; Hiroshi Sato; Huong Thi Nguyen Nguyen; Xu Han; Yu Zhang; Tomoaki Taguchi; Kazuaki Nonaka
Journal:  BMC Neurol       Date:  2018-08-31       Impact factor: 2.474

Review 7.  The power of comparative and developmental studies for mouse models of Down syndrome.

Authors:  Clara S Moore; Randall J Roper
Journal:  Mamm Genome       Date:  2007-07-26       Impact factor: 2.957

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.